Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States
Organization in Davenport, Iowa
630 E 4th St Suite A, Davenport, IA 52801
About Midwest Cardiovascular Research Foundation
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
C. R. Bard
3
Midwest Cardiovascular Research Foundation
3
Shockwave Medical, Inc.
3
Amgen
2
Cardiovascular Systems Inc
2
Pfizer
2
Philips Clinical & Medical Affairs Global
2
Volcano Corporation
2
Abbott Medical Devices
1
AngioSafe, Inc.
1
Angiodynamics, Inc.
1
Clinical Trials at Midwest Cardiovascular Research Foundation
During the past decade, Midwest Cardiovascular Research Foundation conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 18 clinical trials were completed, i.e. on
average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
2007-09-01
2009-05-01
Completed
503
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease
2008-11-01
2012-02-01
Completed
90
Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)
2010-02-01
2011-12-01
Terminated
A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery
2010-07-01
2016-04-01
Completed
276
Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V
2010-06-01
2010-09-01
Completed
1,200
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Midwest Cardiovascular Research Foundation" #1 sponsor was "C. R. Bard" with 3 trials, followed by "Midwest Cardiovascular Research Foundation" with 3 trials
sponsored, "Shockwave Medical, Inc." with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Cardiovascular Systems Inc"
with 2 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Cardiovascular Research Foundation"
#1 collaborator was "Duke Clinical Research Institute" with 3 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator and "Angiodynamics, Inc." with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at Midwest Cardiovascular Research Foundation
According to Clinical.Site data, the most researched conditions in "Midwest Cardiovascular Research Foundation" are
"Peripheral Arterial Disease" (8 trials), "Coronary Artery Disease" (5 trials), "Peripheral Artery Disease" (3 trials), "Peripheral Vascular Disease" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Midwest Cardiovascular Research Foundation" in a lesser frequency.
Clinical Trials Intervention Types at Midwest Cardiovascular Research Foundation
Most popular intervention types in "Midwest Cardiovascular Research Foundation" are "Device" (18 trials), "Drug" (13 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Tack Endovascular System" (2 trials), "Unfractionated Heparin" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Midwest Cardiovascular Research Foundation
The vast majority of trials in "Midwest Cardiovascular Research Foundation" are
36 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Midwest Cardiovascular Research Foundation
Currently, there are NaN active trials in "Midwest Cardiovascular Research Foundation".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 19 completed trials in Midwest Cardiovascular Research Foundation,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Midwest Cardiovascular Research Foundation, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 16 trials that are defined as “Not Applicable".